Triple combination therapies for anti-aging
US-2024316086-A1 · Sep 26, 2024 · US
Glucosyltransferase inhibitor containing epigallocatechin gallate polymer as active ingredient
US9237996B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9237996-B2 |
| Application number | US-200913061073-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 14, 2009 |
| Priority date | Aug 29, 2008 |
| Publication date | Jan 19, 2016 |
| Grant date | Jan 19, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided is a highly palatable and safe glucosyltransferase inhibitor or anti-dental caries agent. A glucosyltransferase inhibitor or anti-dental caries agent having an epigallocatechin gallate polymer or a salt thereof. Particularly, the above agent containing an epigallocatechin gallate polymer, which is a compound in which chroman rings are bonded at position 6 and/or 8 via a methylene group.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for inhibiting glucosyltransferase activity in a subject comprising: preparing an isolated epigallocatechin gallate (EGCG) trimer or a salt thereof from black tea or roasted tea: preparing a composition comprising the isolated EGCG trimer or a salt thereof; and administering the composition to a subject in need thereof; wherein the EGCG trimer or a salt thereof is selected from the group consisting of a compound having the following For…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K8/498Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9237996B2 cover?
- Provided is a highly palatable and safe glucosyltransferase inhibitor or anti-dental caries agent. A glucosyltransferase inhibitor or anti-dental caries agent having an epigallocatechin gallate polymer or a salt thereof. Particularly, the above agent containing an epigallocatechin gallate polymer, which is a compound in which chroman rings are bonded at position 6 and/or 8 via a methylene group.
- Who is the assignee on this patent?
- Fukui Yuko, Nakano Michiyo, Ooshima Takashi, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K8/498. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).